543 related articles for article (PubMed ID: 16962468)
1. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
[TBL] [Abstract][Full Text] [Related]
3. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
4. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
[TBL] [Abstract][Full Text] [Related]
6. Markers of pulmonary hypertension in potential candidates to heart transplantation.
Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
[TBL] [Abstract][Full Text] [Related]
7. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Braun S; Schrötter H; Schmeisser A; Strasser RH
Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
[TBL] [Abstract][Full Text] [Related]
9. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
11. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
12. Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients.
Torres Macho J; Delgado Jimenez JF; Sanz Salvo J; Gonzalez Mansilla A; Sanchez Sanchez V; Gamez Diez S; Escribano Subias P; Saenz de la Calzada C
Transplant Proc; 2009; 41(6):2477-9. PubMed ID: 19715956
[TBL] [Abstract][Full Text] [Related]
13. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
[TBL] [Abstract][Full Text] [Related]
14. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
[TBL] [Abstract][Full Text] [Related]
15. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB
J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
18. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI
Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
[TBL] [Abstract][Full Text] [Related]
19. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
